Page last updated: 2024-11-06

prednisolone and Habermann Disease

prednisolone has been researched along with Habermann Disease in 7 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Febrile ulceronecrotic Mucha-Habermann disease is a rare fulminant variant of pityriasis lichenoides et varioliformis acuta, characterized by a rapidly progressive course with predominant ulceronecrotic lesions associated with fever and systemic manifestations."1.39Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) associated with parvovirus infection. ( Al-Otaibi, M; Al-Sabah, H; Alshalfan, F; Nanda, A; Rajy, JM, 2013)
"This rare variant of pityriasis lichenoides may be under-recognized and misdiagnosed as it resembles a variety of papulosquamous disorders particularly psoriasis."1.31Acral pityriasis lichenoides. ( Kossard, S, 2002)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rojanapanthu, P1
Srisuttiyakorn, C1
Nanda, A1
Alshalfan, F1
Al-Otaibi, M1
Al-Sabah, H1
Rajy, JM1
Lode, HN1
Döring, P1
Lauenstein, P1
Hoeger, P1
Dombrowski, F1
Bruns, R1
Liu, YD1
Zeng, YP1
Wang, YN1
Zhao, WL1
Liu, YH1
Li, L1
Lazaridou, E1
Fotiadou, C1
Tsorova, C1
Trachana, M1
Trigoni, A1
Patsatsi, A1
Ioannides, D1
Pyrpasopoulou, A1
Athyros, VG1
Karagiannis, A1
Chrysomallis, F1
Zamboulis, C1
Kossard, S1

Other Studies

7 other studies available for prednisolone and Habermann Disease

ArticleYear
A young man with necrotic skin lesions.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Fever; Humans; Immunosuppressive Agents; Male; Methotrexate; Necros

2019
Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) associated with parvovirus infection.
    The American Journal of dermatopathology, 2013, Volume: 35, Issue:4

    Topics: Biopsy; Child; Combined Modality Therapy; Glucocorticoids; Humans; Male; Parvoviridae Infections; Pi

2013
Febrile ulceronecrotic Mucha-Habermann disease following suspected hemorrhagic chickenpox infection in a 20-month-old boy.
    Infection, 2015, Volume: 43, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; CD8-Positive T-Lymphocytes; Chickenpox; Cyclosporin

2015
Pityriasis Lichenoides et Varioliformis Acuta and Psoriasis Vulgaris: Mere Coincidence or a Rare Association?
    Chinese medical journal, 2017, 02-20, Volume: 130, Issue:4

    Topics: Adult; Humans; Male; Pityriasis Lichenoides; Prednisolone; Psoriasis; Young Adult

2017
Resistant pityriasis lichenoides et varioliformis acuta in a 3-year-old boy: successful treatment with methotrexate.
    International journal of dermatology, 2010, Volume: 49, Issue:2

    Topics: Biopsy, Needle; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Dr

2010
Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease.
    Dermatology (Basel, Switzerland), 2007, Volume: 215, Issue:2

    Topics: Adolescent; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous

2007
Acral pityriasis lichenoides.
    The Australasian journal of dermatology, 2002, Volume: 43, Issue:1

    Topics: Administration, Topical; Aged; Biopsy, Needle; Female; Follow-Up Studies; Humans; Leg Dermatoses; Ma

2002